Clinical Trial Update: A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics [Phase 2, Phase 3]

View source ↗

Summary

A multicenter randomized trial evaluates prednisone combined with ursodeoxycholic acid for primary biliary cholangitis with moderate to severe interface hepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• PREDNISONE (Prednisone)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Han Ying | Conditions: Primary Biliary Cholangitis (PBC) | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION